Kimberly-Clark is acquiring Tylenol maker Kenvue in a $48.7 billion cash-and-stock deal, creating a major consumer health goods company if shareholders approve.

Canadian pharmacists say a shortage of medications that contain oxycodone is expected to continue into the new year, while ...